Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes ...

Equinox's GLP-1 protocol is considered a framework for people taking the drugs, one that addresses workout intensity, ...

With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...

Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

The makers of Wegovy and Zepbound are cutting prices to make the medications more affordable for people without insurance.